Published in Cancer Causes Control on January 19, 2010
Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res (2010) 0.86
Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Evidence for sexually dimorphic associations between maternal characteristics and anogenital distance, a marker of reproductive development. Am J Epidemiol (2013) 0.78
Human chorionic gonadotropin does not correlate with risk for maternal breast cancer: results from the Finnish maternity cohort. Cancer Res (2016) 0.75
A quality study of a medical birth registry. Scand J Soc Med (1990) 4.96
Epidemiology of breast cancer. Lancet Oncol (2001) 3.58
Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev (2002) 2.39
Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol (2007) 2.34
Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res (2003) 1.79
Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev (2005) 1.66
Mammary developmental fate and breast cancer risk. Endocr Relat Cancer (2005) 1.53
Preeclampsia and breast cancer risk. Epidemiology (1999) 1.47
Antenatal screening for Down's syndrome. Health Technol Assess (1998) 1.45
Prenatal screening for Down syndrome: the problem of recurrent false-positives. Prenat Diagn (2004) 1.44
Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2006) 1.43
IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia (2000) 1.42
Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol (1979) 1.37
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res (2009) 1.35
Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev (2004) 1.34
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res (1998) 1.30
The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update (2006) 1.26
Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia (2002) 1.22
A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev (2001) 1.19
Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab (2008) 1.16
Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States). Cancer Causes Control (2005) 1.11
Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics (2002) 1.10
A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab (2004) 1.08
Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal (1999) 1.08
Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.04
The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res (2005) 1.01
Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control (2003) 1.00
A null association between smoking during pregnancy and breast cancer using Massachusetts registry data (United States). Cancer Causes Control (2003) 0.98
Pregnancy weight gain and breast cancer risk. BMC Womens Health (2004) 0.98
Human placental lactogen and dU-estrogen levels in normal twin pregnancies. Acta Genet Med Gemellol (Roma) (1985) 0.98
Insulin-like growth factor II and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev (2002) 0.95
Correlation of estrogen levels between successive pregnancies. Am J Epidemiol (1995) 0.94
Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer (2005) 0.93
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol (2008) 0.92
Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control (2001) 0.92
Regulation of fetal growth: consequences and impact of being born small. Best Pract Res Clin Endocrinol Metab (2008) 0.92
IGF-I during primiparous pregnancy and maternal risk of breast cancer. Breast Cancer Res Treat (2009) 0.92
Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol (1993) 0.91
Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (1995) 0.91
Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod (2002) 0.91
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst (2000) 0.90
Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations. Br J Cancer (2008) 0.89
Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer (2009) 0.88
Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights. Hum Reprod Update (2008) 0.88
Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann Clin Biochem (2004) 0.86
The influence of smoking and parity on serum markers for Down's syndrome screening. Fetal Diagn Ther (2002) 0.86
Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diagn (1996) 0.86
Co-variables in first trimester maternal serum screening. Prenat Diagn (2000) 0.85
Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 0.84
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 0.83
Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res (2007) 0.82
Effect of fetal gender on first trimester markers and on Down syndrome screening. Prenat Diagn (2001) 0.82
Hormonally induced differentiation: a novel approach to breast cancer prevention. J Cell Biochem Suppl (1995) 0.81
Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening. Prenat Diagn (2002) 0.81
Adjustment of serum markers in first trimester screening. J Med Screen (2009) 0.81
First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. J Med Screen (2008) 0.81
Gender impact on first trimester markers in Down syndrome screening. Prenat Diagn (2002) 0.79
Maternal serum AFP levels in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol (1989) 0.79
Testicular cancer and hormonally active agents. J Toxicol Environ Health B Crit Rev (2008) 0.78
The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG. Prenat Diagn (2000) 0.78
Influence of smoking on serum and milk of mothers, and their infants' serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels. Horm Res (2004) 0.78
The effect of fetal gender on the false-positive rate of Down syndrome by maternal serum screening. Prenat Diagn (2005) 0.77
Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn (2002) 0.77
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer (2005) 3.51
Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ (2005) 3.48
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Consumption of vegetables and fruits and risk of breast cancer. JAMA (2005) 3.02
Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer (2002) 2.60
Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60
Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med (2005) 2.56
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev (2002) 2.42
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19
The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet (2009) 2.17
Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care (2010) 2.14
Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med (2011) 2.01
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am J Epidemiol (2004) 1.91
Obesity and colon cancer: does leptin provide a link? Int J Cancer (2004) 1.89
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer (2010) 1.86
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med (2009) 1.83
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res (2010) 1.82
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
Home abortion implies radical changes for women. Eur J Contracept Reprod Health Care (2009) 1.82
Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 1.78
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scand J Urol Nephrol (2008) 1.74
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab (2006) 1.71
Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol (2012) 1.70
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet (2005) 1.67
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev (2005) 1.67
Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med (2012) 1.67
Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol (2006) 1.66
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66
Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut (2012) 1.66
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer (2008) 1.65
Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol (2012) 1.65
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol (2008) 1.62
Reproducibility of serum cytokines and growth factors. Cytokine (2008) 1.61
Causes of death in the Sami population of Sweden, 1961-2000. Int J Epidemiol (2005) 1.60
Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst (2007) 1.57
Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol (2003) 1.57
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol (2002) 1.56
No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.55
Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol (2004) 1.55
Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Prev Med (2011) 1.55
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer (2004) 1.52
Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med (2013) 1.52
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.52
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol (2007) 1.51
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control (2007) 1.48
Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS One (2011) 1.47
Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden. J Med Virol (2006) 1.47
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther (2006) 1.46
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45
Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr (2009) 1.45
Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control (2002) 1.44
Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer (2006) 1.43
Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol (2009) 1.40
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.40